Cujo;
At one point I was also thinking that it may happen. I have made a numerous postings on this subject on the other site (S*&t Site - no offense to any posters, and every offense to CS, AH moderators)..................If you can find them, you will see that I have put a view that is may prove it to be cost ineffective.
The buyer must purchase 51% and recope this cost within a resonable time frame (usually 3 years). Mind you, this must be done with current production capacity, otherwise the buyer must pay for upgrade to the manufacturing facilities to increase production.
The only reason anyone would want to do this, if it's a valid one, is to corner the market (ie a competitor of VCR - Thoratec). Any other company after that would have to match the VCR device efficiency and the combined market penatration (VCR and buyer), not to mention additional threat of alternative treatments - stem cell/gene therapy!!!!
I guess only time will tell. Hope this helps.
Cheers;
- Forums
- ASX - By Stock
- VCR
- takeover
VCR
ventracor limited
takeover, page-3
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online